Santen Pharmaceutical Co., Ltd. (4536.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 584.97B |
| Enterprise Value | 538.85B |
| P/E Ratio | 14.48 |
| PEG Ratio | 0.48 |
| Price/Sales Ratio | 1.9 |
| Price/Book Ratio | 1.85 |
| Enterprise/Revenue | 1.74 |
| Enterprise/EBITDA | 7.48 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 291.62B |
| Revenue/Share | 908.2 |
| Gross Profit | 160.97B |
| EBITDA | 67.79B |
| Net Income | 37.37B |
| Diluted EPS | 113.8 |
Balance Sheet
| Total Cash | 78.26B |
| Total Cash/Share | 243.53 |
| Total Debt | 31.01B |
| Total Debt/Equity | 0.1 |
| Current Ratio | 2.82 |
| Book Value Per Share | 931.31 |
Price History
| 52-Week Change | 6.51 |
| 52-Week High | 2,254 |
| 52-Week Low | 1,458 |
| Moving Average 50 Days | 1,955.01 |
| Moving Average 200 Days | 1,802.09 |
Statistics
| Average Volume | 1.2M |
| Shares Outstanding | 321.69M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 38 |
| Trailing Annual Dividend Yield | 2.2 |
| Payout Ratio | 0.32 |
| Last Split Factor | 5:1 |
| Last Split Date | March 27, 2015 |
AD
